Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Envestnet Inc. | 30E | 16. oct 2024 | 57.00 | 0.00 |
Envipco Holding | E1P0 | 16. oct 2024 | 5.00 | +1.21 |
EnviroMetal Technologies Inc | 7N20 | 16. oct 2024 | 0.01 | 0.00 |
EnviroSuite Limited | 57P | 16. oct 2024 | 0.04 | +3.85 |
Envista Holdings Corp | 0HV | 16. oct 2024 | 16.00 | 0.00 |
Envitec Biogas AG | ETG | 16. oct 2024 | 32.40 | +2.86 |
Enwave Corp. | E4U | 16. oct 2024 | 0.16 | -5.26 |
Enzo Biochem, Inc. | EZB | 16. oct 2024 | 1.02 | 0.00 |
Enzymatica | EN9 | 16. oct 2024 | 0.13 | -7.69 |
EO2 | EO4 | 16. oct 2024 | 4.15 | -0.48 |
EOG Resources, Inc. | EO5 | 16. oct 2024 | 117.30 | +0.27 |
Eolus Vind B | 7EVB | 16. oct 2024 | 4.02 | -2.31 |
EPAM Systems, Inc. | E3M | 16. oct 2024 | 182.85 | +0.36 |
EPE Special Opportunities Limited | EP0 | 16. oct 2024 | 1.75 | -1.13 |
EPENDION AB SK 0,3333 | TW4 | 16. oct 2024 | 10.16 | +0.59 |
Epigenomics AG | ECX | 16. oct 2024 | 0.61 | +7.77 |
Epiroc A | 3AD1 | 16. oct 2024 | 18.48 | -1.33 |
EPIROC AB UNSP.ADR/1 | 3ADA | 16. oct 2024 | 18.00 | -2.17 |
Epiroc B | 3AD2 | 16. oct 2024 | 16.06 | -3.19 |
Episurf Medical B | 16E | 16. oct 2024 | 0.00 | -85.71 |
ePlay Digital Inc | 2NY2 | 16. oct 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | 16. oct 2024 | 92.50 | -0.54 |
EPR Properties | E2H | 16. oct 2024 | 44.73 | +0.25 |
EPRCOMUNICAZIONE S.P.A. | J3P | 16. oct 2024 | 0.94 | +1.63 |
EPTI AB AK | G7H0 | 16. oct 2024 | 1.98 | +2.86 |
Epwin Group Plc | 2E3 | 16. oct 2024 | 1.17 | 0.00 |
EQB INC. | V22 | 16. oct 2024 | 72.00 | +0.70 |
EQL Pharma | 7JK | 16. oct 2024 | 5.66 | +1.80 |
EQT | 6EQ | 16. oct 2024 | 29.01 | -0.34 |
EQT Corporation | EQ6 | 16. oct 2024 | 33.09 | +0.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.